La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Astellas Pharma Bilan de santé
Santé financière contrôle des critères 2/6
Astellas Pharma has a total shareholder equity of ¥1,676.4B and total debt of ¥992.7B, which brings its debt-to-equity ratio to 59.2%. Its total assets and total liabilities are ¥3,735.5B and ¥2,059.1B respectively. Astellas Pharma's EBIT is ¥95.1B making its interest coverage ratio 53.8. It has cash and short-term investments of ¥302.9B.
Informations clés
59.2%
Ratio d'endettement
JP¥992.66b
Dette
Ratio de couverture des intérêts | 53.8x |
Argent liquide | JP¥302.93b |
Fonds propres | JP¥1.68t |
Total du passif | JP¥2.06t |
Total des actifs | JP¥3.74t |
Mises à jour récentes de la santé financière
Recent updates
Astellas Pharma (TSE:4503) Has Announced That It Will Be Increasing Its Dividend To ¥37.00
Aug 20Earnings Beat: Astellas Pharma Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Aug 04Astellas Pharma's (TSE:4503) Shareholders Will Receive A Bigger Dividend Than Last Year
Jul 26Astellas Pharma (TSE:4503) Is Paying Out A Larger Dividend Than Last Year
Jul 11Is Astellas Pharma (TSE:4503) A Risky Investment?
Jun 14Astellas Pharma's (TSE:4503) Soft Earnings Are Actually Better Than They Appear
May 02Astellas Pharma Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Apr 29Why We're Not Concerned About Astellas Pharma Inc.'s (TSE:4503) Share Price
Feb 29Analyse de la situation financière
Passif à court terme: 4503's short term assets (¥1,240.7B) do not cover its short term liabilities (¥1,373.8B).
Passif à long terme: 4503's short term assets (¥1,240.7B) exceed its long term liabilities (¥685.3B).
Historique et analyse du ratio d'endettement
Niveau d'endettement: 4503's net debt to equity ratio (41.1%) is considered high.
Réduire la dette: 4503's debt to equity ratio has increased from 0.1% to 59.2% over the past 5 years.
Couverture de la dette: 4503's debt is not well covered by operating cash flow (17.4%).
Couverture des intérêts: 4503's interest payments on its debt are well covered by EBIT (53.8x coverage).